Effective biocontrol of grape diseases: assessing and improving efficacy

Code: 9781835454596
Publication date: 07/08/2025
Extent: 48 pages

Contributions by: V. Altieri, P. Battilani, M. Camardo Leggieri, G. Fedele, T. Ji, V. Rossi and I. Salotti, Università Cattolica del Sacro Cuore, Italy

Chapter synopsis:

This chapter reviews the current literature to gather efficacy data on biocontrol in planta for the main diseases and analyzes them quantitatively. A meta-analysis of these data was carried out in selected cases (powdery mildew, trunk diseases, and certain species of Aspergillus producing ochratoxin A). Ways to improve the efficacy and consistency of the biocontrol is also discussed. The chapter concludes with a step-by-step outline, describing the steps required for the effective biocontrol of grape diseases. The pathogen stage for which biocontrol is required should firstly be defined, as well as the mechanism of action needed for the control. Next, suitable microorganisms should be defined based on their ability to thrive in the same environment as the pathogen, so that the BCA may grow when the pathogen grows.



DOI: 10.19103/AS.2024.0142.18
£25.00
Buy ePub   
Table of contents
  • 1 Introduction
  • 2 Current research on biocontrol of grape diseases: an overview
  • 3 Assessing the efficacy of biological control agents (BCAs) against grapevine diseases
  • 4 Biocontrol efficacy against downy mildew
  • 5 Biocontrol efficacy against powdery mildew
  • 6 Biocontrol efficacy against grey mould
  • 7 Biocontrol efficacy against trunk diseases
  • 8 Biocontrol efficacy against ochratoxigenic fungi and sour rot
  • 9 General lessons from the literature on efficacy
  • 10 Understanding and improving biological control efficacy through network meta-analysis: powdery mildew, trunk diseases, and my
  • 11 Improving biocontrol efficacy through understanding interactions between pathogen, plant and environmental conditions: Plasmopora viticola, Erysiphe necator, and Botrytis cinerea
  • 12 Conclusions
  • 13 Data availability statement
  • 14 Conflict of interest
  • 15 Author Contributions
  • 16 Acknowledgments
  • 17 References

Also in Diseases